Details for New Drug Application (NDA): 072995
✉ Email this page to a colleague
NDA 072995 describes METOCLOPRAMIDE INTENSOL, which is a drug marketed by Roxane and is included in one NDA. Additional details are available on the METOCLOPRAMIDE INTENSOL profile page.
The generic ingredient in METOCLOPRAMIDE INTENSOL is metoclopramide hydrochloride. There are fourteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
The generic ingredient in METOCLOPRAMIDE INTENSOL is metoclopramide hydrochloride. There are fourteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
Summary for 072995
| Tradename: | METOCLOPRAMIDE INTENSOL |
| Applicant: | Roxane |
| Ingredient: | metoclopramide hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072995
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CONCENTRATE;ORAL | Strength | EQ 10MG BASE/ML | ||||
| Approval Date: | Jan 30, 1992 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
